A comparison of cathepsin D levels in endometriotic tissue and in uterine endometrium

被引:23
作者
Bergqvist, A
Ferno, M
Mattson, S
机构
[1] UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN
[2] MALMO UNIV HOSP, DEPT OBSTET & GYNECOL, MALMO, SWEDEN
关键词
endometriosis; endometrium; cathepsin D; growth regulation; proteolysis;
D O I
10.1016/S0015-0282(16)58326-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assay the cathepsin D level in endometriotic tissue, to study the difference to uterine endometrium and the correlation to localization. Design: Prospective consecutive study on endometriotic tissue and endometrium. Setting: University clinic. Patients: Thirty-five women undergoing laparotomy for clinical indications. Interventions: Samples of endometriotic tissue and uterine endometrium were obtained simultaneously from the same woman at laparotomy, fresh frozen, and assayed using an immunoradiometric method. Main Outcome Measure: The cathepsin D level in endometrium and endometriotic tissue expressed in pmol/mg DNA. Results: The cathepsin D level was significantly higher in endometriotic tissue than in endometrium both in follicular and luteal phase. The highest values in endometriotic tissue were found in luteal phase, in ovarian lesions, and in primary lesions. In endometrium, but not in endometriotic tissue, there was a positive correlation between cathepsin D level and serum E(2) level. Conclusion: The level of the proteolytic enzyme cathepsin D is significantly higher in endometriotic tissue than in endometrium, which might be of importance for implantation and the invasive growth of endometriotic tissue.
引用
收藏
页码:1130 / 1134
页数:5
相关论文
共 22 条
  • [1] ESTROGEN AND PROGESTERONE RECEPTORS IN ENDOMETRIOTIC TISSUE AND ENDOMETRIUM - COMPARISON OF DIFFERENT CYCLE PHASES AND AGES
    BERGQVIST, A
    FERNO, M
    [J]. HUMAN REPRODUCTION, 1993, 8 (12) : 2211 - 2217
  • [2] BERGQVIST A, 1985, AM J PATHOL, V121, P337
  • [3] Bergqvist A., 1991, ANN NY ACAD SCI, V626, P276, DOI 10.1111/j.1749-6632.1991.tb37922.x
  • [4] CATHEPSIN D ASSAY IN PRIMARY BREAST-CANCER AND LYMPH-NODES - RELATIONSHIP WITH C-MYC, C-ERB-B-2 AND INT-2 ONCOGENE AMPLIFICATION AND NODE INVASIVENESS
    BROUILLET, JP
    THEILLET, C
    MAUDELONDE, T
    DEFRENNE, A
    SIMONYLAFONTAINE, J
    SERTOUR, J
    PUJOL, H
    JEANTEUR, P
    ROCHEFORT, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) : 437 - 441
  • [6] ESTROGENS AND GROWTH-FACTORS INDUCE THE MESSENGER-RNA OF THE 52K-PRO-CATHEPSIN-D SECRETED BY BREAST-CANCER CELLS
    CAVAILLES, V
    AUGEREAU, P
    GARCIA, M
    ROCHEFORT, H
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (05) : 1903 - 1919
  • [7] DUFFY MJ, 1991, CLIN CHEM, V37, P101
  • [8] PLASMINOGEN ACTIVATORS IN ECTOPIC AND UTERINE ENDOMETRIUM
    FERNANDEZSHAW, S
    MARSHALL, JM
    HICKS, B
    BARLOW, DH
    STARKEY, PM
    [J]. FERTILITY AND STERILITY, 1995, 63 (01) : 45 - 51
  • [9] CATHEPSIN-D, BOTH A PROGNOSTIC FACTOR AND A PREDICTIVE FACTOR FOR THE EFFECT OF ADJUVANT TAMOXIFEN IN BREAST-CANCER
    FERNO, M
    BALDETORP, B
    BORG, A
    BROUILLET, JP
    OLSSON, H
    ROCHEFORT, H
    SELLBERG, G
    SIGURDSSON, H
    KILLANDER, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (14) : 2042 - 2048
  • [10] IMMUNOHISTOCHEMICAL DISTRIBUTION OF THE 52-KDA PROTEIN IN MAMMARY-TUMORS - A MARKER ASSOCIATED WITH CELL-PROLIFERATION RATHER THAN WITH HORMONE RESPONSIVENESS
    GARCIA, M
    LACOMBE, MJ
    DUPLAY, H
    CAVAILLES, V
    DEROCQ, D
    DELARUE, JC
    KREBS, B
    CONTESSO, G
    SANCHOGARNIER, H
    RICHER, G
    DOMERGUE, J
    NAMER, M
    ROCHEFORT, H
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 27 (1-3) : 439 - 445